- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
3-AMINO-1,2,4-TRIAZINE
Product Name:3-AMINO-1,2,4-TRIAZINE
Formulae hypotheticae: C3H4N4
Molecular pondus: 96.09
CAS Subcriptio Number: 1120-99-6
6-broMo-1,2,4-triazin-3-aMine
Product Name:6-broMo-1,2,4-triazin-3-aMine
Formulae hypotheticae: C3H3BrN4
Molecular pondus:174.99
CAS Subcriptio Number:69249-22-5
methyl(R)-2-(1-((2-aminopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate
Product Name: methyl(R)-2-(1-((2-aminopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate
Formulae hypotheticae: C15H15FN2O3
Molecularis ponderis: 290.29
CAS Registry Number: 1454847-99-4
(S) -1-(5-fluoro-2-iodophenyl)ethan-1-ol
Product Name:(S) -1-(5-fluoro-2-iodophenyl)ethan-1-ol
Formulae hypotheticae: C8H8FIO
Molecular pondus:266.05
CAS Subcriptio Number:1454847-96-1
1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloride
Product Name:1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloride
Formulae hypotheticae: C7H11ClN4
Molecular pondus:186,64
CAS Subcriptio Number:1643141-20-1
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl) methyl)
Product Name: tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl) methyl)(methyl) carbamate
Formulae hypotheticae: C12H17BrN4O2
Molecular pondus:329,19
CAS Registry Number: 1454848-24-8
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
